Glentuss is a Oral Syrup in the Human Otc Drug category. It is labeled and distributed by Glendale Inc. The primary component is Dextromethorphan Hydrobromide; Pseudoephedrine Hydrochloride; Doxylamine Succinate.
Product ID | 70147-233_f23182eb-a618-4556-a265-3de318cc7ae5 |
NDC | 70147-233 |
Product Type | Human Otc Drug |
Proprietary Name | Glentuss |
Generic Name | Dextromethorphan Hydrobromide, Pseudoephedrine Hydrochloride, And Doxylamine Succinate |
Dosage Form | Syrup |
Route of Administration | ORAL |
Marketing Start Date | 2015-12-05 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Glendale Inc |
Substance Name | DEXTROMETHORPHAN HYDROBROMIDE; PSEUDOEPHEDRINE HYDROCHLORIDE; DOXYLAMINE SUCCINATE |
Active Ingredient Strength | 15 mg/5mL; mg/5mL; mg/5mL |
NDC Exclude Flag | E |
Listing Certified Through | 2017-12-31 |
Marketing Start Date | 2015-12-05 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC MONOGRAPH FINAL |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2015-12-05 |
Inactivation Date | 2020-01-31 |
Ingredient | Strength |
---|---|
DEXTROMETHORPHAN HYDROBROMIDE | 15 mg/5mL |
SPL SET ID: | 8a6eb670-8bed-4941-b4fd-70b3f1e48401 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |